These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
299 related items for PubMed ID: 17699638
21. Acid-sensitive TASK-like K+ conductances contribute to resting membrane potential and to orexin-induced membrane depolarization in rat thalamic paraventricular nucleus neurons. Doroshenko P, Renaud LP. Neuroscience; 2009 Feb 18; 158(4):1560-70. PubMed ID: 19135504 [Abstract] [Full Text] [Related]
22. Modulation of cardiac inward rectifier K(+)current by halothane and isoflurane. Stadnicka A, Bosnjak ZJ, Kampine JP, Kwok WM. Anesth Analg; 2000 Apr 18; 90(4):824-33. PubMed ID: 10735783 [Abstract] [Full Text] [Related]
23. In vitro effects of propofol and volatile agents on pharmacologically induced chloride channel myotonia. Bandschapp O, Ginz HF, Soule CL, Girard T, Urwyler A, Iaizzo PA. Anesthesiology; 2009 Sep 18; 111(3):584-90. PubMed ID: 19672179 [Abstract] [Full Text] [Related]
24. The TASK-1 two-pore domain K+ channel is a molecular substrate for neuronal effects of inhalation anesthetics. Sirois JE, Lei Q, Talley EM, Lynch C, Bayliss DA. J Neurosci; 2000 Sep 01; 20(17):6347-54. PubMed ID: 10964940 [Abstract] [Full Text] [Related]
26. A TREK-1-like potassium channel in atrial cells inhibited by beta-adrenergic stimulation and activated by volatile anesthetics. Terrenoire C, Lauritzen I, Lesage F, Romey G, Lazdunski M. Circ Res; 2001 Aug 17; 89(4):336-42. PubMed ID: 11509450 [Abstract] [Full Text] [Related]
27. Contribution of TWIK-related acid-sensitive K+ channel 1 (TASK1) and TASK3 channels to the control of activity modes in thalamocortical neurons. Meuth SG, Budde T, Kanyshkova T, Broicher T, Munsch T, Pape HC. J Neurosci; 2003 Jul 23; 23(16):6460-9. PubMed ID: 12878686 [Abstract] [Full Text] [Related]
28. The ventilatory stimulant doxapram inhibits TASK tandem pore (K2P) potassium channel function but does not affect minimum alveolar anesthetic concentration. Cotten JF, Keshavaprasad B, Laster MJ, Eger EI, Yost CS. Anesth Analg; 2006 Mar 23; 102(3):779-85. PubMed ID: 16492828 [Abstract] [Full Text] [Related]
30. Serotonergic raphe neurons express TASK channel transcripts and a TASK-like pH- and halothane-sensitive K+ conductance. Washburn CP, Sirois JE, Talley EM, Guyenet PG, Bayliss DA. J Neurosci; 2002 Feb 15; 22(4):1256-65. PubMed ID: 11850453 [Abstract] [Full Text] [Related]
31. Comparative myocardial depression of sevoflurane, isoflurane, and halothane in cultured neonatal rat ventricular myocytes. Kanaya N, Kawana S, Tsuchida H, Miyamoto A, Ohshika H, Namiki A. Anesth Analg; 1998 Nov 15; 87(5):1041-7. PubMed ID: 9806680 [Abstract] [Full Text] [Related]
33. Identification of native rat cerebellar granule cell currents due to background K channel KCNK5 (TASK-2). Cotten JF, Zou HL, Liu C, Au JD, Yost CS. Brain Res Mol Brain Res; 2004 Sep 28; 128(2):112-20. PubMed ID: 15363886 [Abstract] [Full Text] [Related]
34. The effects of halothane, isoflurane, and sevoflurane on Ca2+ current and transient outward K+ current in subendocardial and subepicardial myocytes from the rat left ventricle. Rithalia A, Hopkins PM, Harrison SM. Anesth Analg; 2004 Dec 28; 99(6):1615-1622. PubMed ID: 15562042 [Abstract] [Full Text] [Related]
35. Electrophysiologic mechanism underlying action potential prolongation by sevoflurane in rat ventricular myocytes. Chae JE, Ahn DS, Kim MH, Lynch C, Park WK. Anesthesiology; 2007 Jul 28; 107(1):67-74. PubMed ID: 17585217 [Abstract] [Full Text] [Related]
37. Carvedilol targets human K2P 3.1 (TASK1) K+ leak channels. Staudacher K, Staudacher I, Ficker E, Seyler C, Gierten J, Kisselbach J, Rahm AK, Trappe K, Schweizer PA, Becker R, Katus HA, Thomas D. Br J Pharmacol; 2011 Jul 28; 163(5):1099-110. PubMed ID: 21410455 [Abstract] [Full Text] [Related]
38. The in vivo contributions of TASK-1-containing channels to the actions of inhalation anesthetics, the alpha(2) adrenergic sedative dexmedetomidine, and cannabinoid agonists. Linden AM, Aller MI, Leppä E, Vekovischeva O, Aitta-Aho T, Veale EL, Mathie A, Rosenberg P, Wisden W, Korpi ER. J Pharmacol Exp Ther; 2006 May 28; 317(2):615-26. PubMed ID: 16397088 [Abstract] [Full Text] [Related]